Literature DB >> 30513253

Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment.

Johann Steiner1,2, Harald Prüss3, Stephan Köhler4, Thomas Frodl1,2, Alkomiet Hasan5, Peter Falkai5.   

Abstract

Objectives: Despite intensive research, schizophrenia and schizoaffective disorders continue to be theoretical constructs that describe clinical syndromes and no pathophysiologically defined diseases. Moreover, there are no clear biomarkers at hand. Therefore, these diagnoses are still set up based on clinical ICD-10/DSM-5 criteria and the exclusion of alcohol-/drug-associated, systemic or other brain organic causes.
Methods: Recently, autoimmune encephalitis with psychotic symptoms caused by specific antineuronal antibodies has been identified as a rare, but potentially treatable differential diagnosis. However, these inflammatory brain diseases are not reliably detected by our current routine diagnostic workup in psychiatry. This qualitative review provides structured diagnostic and therapeutic support for clinical practice.
Results: Disturbances of consciousness and orientation, catatonia, speech dysfunction, focal neurological signs, epileptic seizures/EEG abnormalities or autonomic dysfunction are warning signs in psychiatric patients which should always induce cerebrospinal fluid analysis with determination of antineuronal autoantibodies. Currently established immunotherapy strategies are summarised, taking into account international expert advice.Conclusions: Guided by clinical warning signs, our qualitative review enables rapid and reliable diagnosis of definite autoimmune encephalitis. This is of high relevance for the affected individuals, since early and sufficiently intense immunotherapy often leads to a good prognosis despite severe illness.

Entities:  

Keywords:  Antineuronal antibodies; autoimmune encephalitis; limbic encephalitis; psychosis; schizophrenia

Year:  2019        PMID: 30513253     DOI: 10.1080/15622975.2018.1555376

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  16 in total

Review 1.  Acute and Transient Psychotic Disorders: Newer Understanding.

Authors:  Savita Malhotra; Swapnajeet Sahoo; Srinivas Balachander
Journal:  Curr Psychiatry Rep       Date:  2019-11-04       Impact factor: 5.285

2.  Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study.

Authors:  Shan Qiao; Huai-Kuan Wu; Ling-Ling Liu; Mei-Ling Wang; Ran-Ran Zhang; Tao Han; Xue-Wu Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-25       Impact factor: 2.570

Review 3.  Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations.

Authors:  Dominique Endres; Frank Leypoldt; Karl Bechter; Alkomiet Hasan; Johann Steiner; Katharina Domschke; Klaus-Peter Wandinger; Peter Falkai; Volker Arolt; Oliver Stich; Sebastian Rauer; Harald Prüss; Ludger Tebartz van Elst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-03-12       Impact factor: 5.270

4.  Cerebrospinal fluid findings in patients with psychotic symptoms-a retrospective analysis.

Authors:  Tim W Rattay; Pascal Martin; Debora Vittore; Holger Hengel; Idil Cebi; Johannes Tünnerhoff; Maria-Ioanna Stefanou; Jonatan F Hoffmann; Katrin von der Ehe; Johannes Klaus; Julia Vonderschmitt; Matthias L Herrmann; Paula Bombach; Hazar Al Barazi; Lena Zeltner; Janina Richter; Klaus Hesse; Kathrin N Eckstein; Stefan Klingberg; Dirk Wildgruber
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

5.  Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers.

Authors:  Christian G Bien; Cathrin Rohleder; Juliane K Mueller; Corinna I Bien; Dagmar Koethe; F Markus Leweke
Journal:  Front Psychiatry       Date:  2021-03-26       Impact factor: 4.157

6.  Considerations of psychotic symptomatology in anti-NMDA encephalitis: Similarity to cycloid psychosis.

Authors:  Eloi Giné Servén; Ester Boix Quintana; Nicolau Guanyabens Buscà; Virginia Casado Ruiz; Cristina Torres Rivas; Marta Niubo Gurgui; Josep Dalmau; Carol Palma
Journal:  Clin Case Rep       Date:  2019-11-07

7.  Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.

Authors:  Johann Steiner; Thomas Frodl; Kolja Schiltz; Henrik Dobrowolny; Roland Jacobs; Brisa S Fernandes; Paul C Guest; Gabriela Meyer-Lotz; Katrin Borucki; Sabine Bahn; Bernhard Bogerts; Peter Falkai; Hans-Gert Bernstein
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

8.  Cycloid psychosis as a psychiatric expression of anti-NMDAR encephalitis. A systematic review of case reports accomplished with the authors' cooperation.

Authors:  Eloi Giné Servén; Ester Boix Quintana; Maria Martínez Ramírez; Nicolau Guanyabens Buscà; Desiree Muriana Batiste; Mar Guasp; Cristina Torres Rivas; Eva Davi Loscos; Virginia Casado Ruiz
Journal:  Brain Behav       Date:  2020-12-03       Impact factor: 3.405

Review 9.  Early Detection and Prevention of Schizophrenic Psychosis-A Review.

Authors:  Martin Lennart Schulze Westhoff; Johannes Ladwig; Johannes Heck; Rasmus Schülke; Adrian Groh; Maximilian Deest; Stefan Bleich; Helge Frieling; Kirsten Jahn
Journal:  Brain Sci       Date:  2021-12-23

Review 10.  Psychological and neuropsychiatric implications of COVID-19.

Authors:  E B Mukaetova-Ladinska; G Kronenberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-11-22       Impact factor: 5.760

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.